NCT01698164

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,200 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: Female
• Age: 40 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the benefit/risk of hormone replacement treatment among early menopausal women in China. This is a multi-centre, random, prospective study.

Conditions

• Menopausal Syndrome
• Cardiovascular Disease
• Osteoporosis
• Breast Cancer

Interventions

Type	Name	Description
DRUG	estradiol plus MPA	Participants are given estradiol and synthetic progestin.
DRUG	Ximingting Tablet	Participants are given phytoestrogen.
DRUG	estradiol plus progesterone	Participants are given estradiol and natural progesterone.

Timeline

• Start date: 2008-12-01
• Primary completion: 2012-10-01
• First posted: 2012-10-02
• Last updated: 2012-10-02

Locations

1 site across 1 country: China